The species of the genus Trillium (Melanthiaceae alt. Trilliaceae) include perennial herbs with characteristic rhizomes mainly distributed in Asia and North America. Steroids and saponins are the main classes of phytochemicals present in these plants. This review summarizes and discusses the current knowledge on their chemistry, as well as the in vitro and in vivo studies carried out on the extracts, fractions and isolated pure compounds from the different species belonging to this genus, focusing on core biological properties, i.e., cytotoxic, antifungal and anti-inflammatory activities.
Introduction
Natural products obtained from plants have played remarkable role in drug discovery and improvement of health care system [1] [2] [3] [4] [5] [6] . According to the World Health Organization (WHO) estimate, about 80% of world population relies on natural sources for their primary health care need while the remaining 20% of the population uses integrated natural sources [7] . Even at the dawn of 21st century, 11% of the 252 drugs considered as basic and essential by the WHO were exclusively of flowering plants origin [8] . At present, the area of cancer and infectious diseases are mostly dependent on natural products, and among the 175 approved anti-cancer drug molecules, 85 (49%) are either natural products or their derivatives [3] .
In scientific literature around the world, more than 35,000 plant species have been reported to be used in different human cultures for medicinal purposes [9] . Nevertheless, this number could be much higher, as knowledge of indigenous use of medicinal plants mainly passes verbally from one generation to another and largely remains undocumented. Among the 250,000 reported higher plant species, only 5-15% has been scrutinized for their bioactive molecules [10] . Therefore, medicinal plants represent an area under focus since their secondary metabolites encompass a significant number of drugs used in current therapeutics and their potential as source of new medicines is beyond any doubts.
Saponins are steroid or triterpene glycosides widely distributed in the plants that possess hemolytic properties and poisonous effects [11] . The aglycone part (sapogenin) of saponins may have steroid or triterpenoid nuclei, based on whom saponins are generally classified. Steroidal saponins are less common and usually found in monocotyledonous plants as compared to triterpenoid saponins, 
Phytochemicals of the Genus Trillium
The genus Trillium is a rich source of bioactive phytochemicals as steroids, saponin derivatives and flavonoids [25] [26] [27] [28] [29] . Thus far, several steroidal saponins have been isolated and purified from the plants belonging to this genus and, at present, novel metabolites/phytochemicals from Trillium ssp. are investigating using the latest technologies [30] [31] [32] [33] [34] . The secondary metabolites/phytochemicals of species belonging to the genus Trillium are reported in Table 2 . 
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Source
Chemical Name Chemical Structure References
T. erectum (25S)-spirost-5-ene-3β,17α,27-triol (compound 2) [26] T. erectum
[28]
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T. erectum (25S)-spirost-5-ene-3β,17α,27-triol (compound 2) [26] T. erectum (25S)-3β,17α-dihydroxyspirost-5-en-27-yl β-D-glucopyranoside (compound 3) [26] [26]
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glucopyranoside (compound 20)
T kamtschaticum T. kamtschaticum
T. kamtschaticum T. kamtschaticum Deoxytrillenoside (compound 26) [35, 38] T. kamtschaticum
[35] T. kamtschaticum Deoxytrillenoside (compound 26) [35, 38] T. kamtschaticum
26-O-β-D-glucopyranosyl (22,[25R)-[furost-5-eene-3β, 17α,22,26-tetraol 3-O-α-Lrhamnopyranosyl-(1→2)-O-β-D-glucopyra noside (compound 27)
26-O-β-D-glucopyranosyl 17(20)-dehydrokryptogenin 3-O-α-L-rhamnopyranosyl-(1→2)-O-β-D-glucopyranoside (compound 30)
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26-O-β-D-glucopyranosyl 17(20)-dehydrokryptogenin 3-O-α-L-rhamnopyranosyl-(1→2)-O-β-D-gl ucopyranoside (compound 30)
T. govanianum Govanoside A (compound 31) [28] T. govanianum Borassoside E (compound 32) [28] T. tschonoskii
[39]
T. tschonoskii (25S)-27-hydroxypenogenin-[3-O-α-L-rham nopyranosyl-(1→2)-O-β-D-glucopyranosid e] (compound 34)
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T. govanianum Borassoside E (compound 32) [28] T. tschonoskii
T. tschonoskii Other non-steroidal compounds
T. kamtschaticum
(10R,6E)-7,11-dimethyl-3-mehyl3ene-6-dod ecaene-1,2,10,11-tetraol 10-O-β-D-glucopyranoside (compound 38) [35] T. kamtschaticum (10R,6E)-3,7,11-trimethyl-1,6-dodecadien-3 ,10,11-triol 10-O-glucopyranoside (compound 39) [35] T. kamtschaticum (10R,6E)-3,7,11-trimethyl-1,6-dodecadien-3 ,10,11-triol 10-O-glucopyranoside (compound 40)
T. tschonoskii
T. tschonoskii Methylferulorate (compound 42) [41] [19]
Other non-steroidal compounds Other non-steroidal compounds
T. tschonoskii Methylferulorate (compound 42) [41] [35]
T. kamtschaticum (10R,6E)-3,7,11-trimethyl-1,6-dodecadien-3,10,11-triol 10-O-glucopyranoside (compound 39) Other non-steroidal compounds
T. kamtschaticum T. govanianum 5 hydroxy, β-ecdysone(5,20 dihydroxyecdysone) (compound 37) [19] Other non-steroidal compounds
(10R,6E)-7,11-dimethyl-3-mehyl3ene-6-dod ecaene-1,2,10,11-tetraol 10-O-β-D-glucopyranoside (compound 38) [35] T. kamtschaticum (10R,6E)-3,7,11-trimethyl-1,6-dodecadien-3 ,10,11-triol 10-O-glucopyranoside (compound 39)
T. kamtschaticum (10R,6E)-3,7,11-trimethyl-1,6-dodecadien-3 ,10,11-triol 10-O-glucopyranoside (compound 40)
T. tschonoskii [29, 35] T. govanianum 5 hydroxy, β-ecdysone(5,20 dihydroxyecdysone) (compound 37) [19] Other non-steroidal compounds
T. tschonoskii Methylferulorate (compound 42) [41] [41] T. kamtschaticum (10R,6E)-3,7,11-trimethyl-1,6-dodecadien-3 ,10,11-triol 10-O-glucopyranoside (compound 40) [35] T. tschonoskii
T. tschonoskii Methylferulorate (compound 42)
T. kamtschaticum Astragalin (compound 43)
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T. kamtschaticum Astragalin (compound 43) [35] T. undulatum 3,4,5,7-tetrahydroxyflavone (compound 44) [27] T. undulatum
T. undulatum
T. tschonoskii p-hydroxymethyl benzyl alcohol (compound 47) [42] T. govanianum Govanic acid (compound 48) [19] T. tschonoskii 3,7,11-trimethyl-3,9,11-trihydroxyl-1,6-dod ecadiene glycerol (compound 49) [42] T. tschonoskii 2-methyl-3,4 dihydroxy-hexanedioic acid (compound 50) [42] 
Medicinal Importance and Biological Activities of the Genus Trillium
Plant species belonging to the genus Trillium have been extensively used as a remedy for various diseases in different traditional healing systems and several preclinical studies have corroborated these uses. The reported biological/pharmacological activities of different species indicate the promising potential of crude extracts, solvent fractions and isolated pure compounds. T. kamtschaticum Astragalin (compound 43) [35] T. undulatum 3,4,5,7-tetrahydroxyflavone (compound 44) [27] T. undulatum
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[42]
T. tschonoskii 2-methyl-3,4 dihydroxy-hexanedioic acid (compound 50) T. undulatum
The rhizomes of T. erectum, named beth roots, have been used in folk medicine for the treatment of hemorrhages from uterus, urinary tract and lungs [43] . T. tschonoskii has been traditionally used in China for at least one thousand years [44, 45] . Dried rhizomes of this plant species have been used as herbal remedy for treatment of hypertension, neurasthenia, giddiness, headache, removing carbuncles and ameliorating pains [46, 47] . The anticancer and pro-apoptotic activities of n-BuOH extract against human lung cancer cells have also been demonstrated [45] .
The ethanol, ethyl acetate and butanol extracts of T. tschonoskii significantly suppressed the edema of rat hind paw swelling elicited by injection of carrageenan [48] . Finally, T. tschonoskii improved learning and memory in rats, by enhancing the expression of anti-oxidase enzymes [49] .
Ethanol extract from rhizomes and aerial parts of T. grandiflorum exhibited antifungal activity [40] . The rhizome of T. govanianum is commonly known as "matar zela" or "teen patra" in Pakistan, and "nag chatri" in India [19] . In folk medicine, T. govanianum is used to cure dysentery and boils; in wound healing, and menstrual and sexual disorders; and as anti-inflammatory and antiseptic agent [50] . The powdered roots are used as body and sexual tonic [51] . Noteworthy, analgesic, anti-inflammatory, antifungal, free radical scavenging, β-glucuronidase inhibitory activities as well as cytotoxicity against prostate and cervical carcinoma cells of T. govanianum have been recently reported [19, 29, 50] .
Bioactivities of the Genus Trillium Phytochemicals
The isolated secondary metabolites of the genus Trillium mostly belong to the chemical class of steroidal saponins and steroids, including ecdysteroids, even if flavonoids and trihydroxy fatty acids have also been reported. The isolated compounds exhibited a remarkable potential when tested in different in vitro and in vivo assays. Thus far, among the tested steroidal saponins, both spirostanol and furostanol saponins, many of them exhibited relevant cytotoxicity against different cancer cell lines, few showed high potential against tested fungal strains, while some of them possessed antioxidant and COX-2 inhibitory activity, as reported in Table 3 . Table 3 . Bioactivities of the genus Trillium phytochemicals.
Source
Compound Reported Pharmacological Activity
Cytotoxic, anti-proliferative and morphological effects on lung cancer cell line [52] ; cytotoxicity against malignant sarcoma cells Cytotoxicity against HL-60 human promyelocytic leukemia cells, IC 50 (µg/mL) = 2.89 ± 0.24 [26] Antifungal activity against Aspergillus niger, A. flavus, Candida albicans, C. glabrata, Trichophyton rubrum [19, 28] pennogenin (compound 35), borassoside E (compound 32), diosgenin (compound 1) ROS inhibitory activity [51] T. kamtschaticum Antifungal activity against Candida albicans MIC (µg/mL) = 1.56 [40] In addition, the biological activities of steroidal saponins mainly depend on their aglycone moieties (steroidal sapogenins) as well as the number and structure of monosaccharide units in their sugar chains. A slight structural diversity endorses a significant difference on their antifungal and cytotoxic properties, i.e., spirostanol saponins exhibit a higher antifungal potential in comparison to their analogous furostanol saponins. Therefore, it is worth mentioning that further detailed studies on the structure-activity relationships (SAR) and molecular/biochemical targets of steroidal saponins are required to explore the therapeutic potential of this important class of natural products as leads for new drug discovery.
Conclusions and Future Perspectives
Thus far, more than 40 steroidal saponins having spirostane and furostane type aglycons from the genus Trillium have been isolated. Their structure was determined by the use of spectroscopic techniques, including fast atom bombardment mass spectrometry (FABMS) and extensive 2D nuclear magnetic resonance (NMR) experiments (COSY, TOCSY, NOESY, HSQC, and HMBC). The existing data strongly suggest that plants belonging to the genus Trillium are rich source of steroids and saponins and possess a therapeutic potential in the management of cancers, fungal infections, inflammatory and painful disorders. Noteworthy, most of the plant species are still unexplored, and some are under investigation; therefore, further comprehensive studies are needed to screen new sources of phytochemicals to develop promising phytotherapeutics effective in the treatment of chronic degenerative and infectious diseases. Finally, the most promising Trillium secondary metabolites have to be investigated in humans, in properly designed randomized clinical trials, to reach the highest level of clinical evidence.
